ONTY Related Analyst Ratings

May 17, 2013 12:47 PM Wedbush Upgrades Oncothyreon (ONTY) to Outperform

Mar 15, 2013 11:38 AM Cantor Fitzgerald Slashes PT on Oncothyreon (ONTY) from $11 to $4

Jan 17, 2013 05:42 PM Piper Jaffray Starts Oncothyreon (ONTY) at Underweight

Aug 24, 2012 06:57 AM Stifel Nicolaus Starts Oncothyreon (ONTY) at Buy

May 23, 2012 08:26 AM WBB Securities Upgrades Oncothyreon (ONTY) to Hold

Jan 25, 2012 07:14 AM Cantor Fitzgerald Starts Oncothyreon (ONTY) at Buy; All About Stimuvax

Jan 24, 2012 10:25 AM JMP Securities Lifts Price Target On Oncothyreon (ONTY) to $14

Dec 28, 2011 07:42 AM Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)

Nov 16, 2011 01:23 PM Wedbush Boosts Target on Outperform-Rated Oncothyreon (ONTY) to $31 Ahead of STIMUVAX Phase III Data

May 31, 2011 09:11 AM Cowen Starts Oncothyreon (ONTY) at Outperform

Apr 25, 2011 02:33 PM Rodman & Renshaw Starts Oncothyreon (ONTY) at Market Outperform, Sets Street-High Price Target at $10

Mar 14, 2011 04:56 PM Wedbush Starts Oncothyreon (ONTY) at Outperform; Market is Undervaluing Assets

Aug 13, 2010 11:55 AM JMP Securities Initiates Coverage on Oncothyreon (ONTY) with an Market Outperform

Jul 15, 2010 08:37 AM Roth Capital Initiates Coverage on Oncothyreon (ONTY) with a Buy

May 21, 2010 12:06 PM Oncothyreon (ONTY) Shares On The Move as Rodman & Renshaw Restarts at Market Outperform

Feb 17, 2010 09:57 AM WBB Securities Initiates Coverage on Oncothyreon (ONTY) with a Sell

Jun 18, 2009 09:38 AM Boenning & Scattergood initiates coverage on Oncothyreon (ONTY) with an Outperform